... be richer in defense chemicals—can significantly improve the efficiency and lower the cost of drug discovery, when compared with a random screening approach.
Although the idea that brightly colored ...
... "SIRTUINS - Novel Therapeutic Targets to Treat Age-Associated Diseases," the review appears in today's issue of the journal Nature Reviews Drug Discovery.
... hope the success of distributed problem solving at the computational and synthetic stages of drug discovery will encourage their biological colleagues to develop simple, inexpensive tests to enable ...
... barrier and opens up access to membrane proteins - this has exciting clinical implications as it may enable drug discovery on receptors that are currently too difficult to produce or study by current ...
... to bind to.
They tested the agent in laboratory cell culture, and with the help of GUMC's Drug Discovery Program, the researchers designed a stronger derivative compound they called YK-4-279. In ...
... Institute for Medical Research at Lake Nona announced today that they will begin a multidisciplinary drug discovery collaboration to identify novel marine microbial compounds that have potential as ...
... testing time to a matter of weeks. The current drug discovery process is arduous, requiring identification ... almost every cellular process. Most current drugs act by wedging themselves into small pockets ...
... of print Sept. 17, 2009, in the scientific journal Rapid Communications in Mass Spectrometry.
In the drug discovery field, scientists use what is known as a "high-throughput screening system" to ...
Cancer and cell biology experts have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts.
Canada really needs a national drug development niche, Stephen Strauss writes
... of agents now in testing to treat Alzheimer's disease work, and say they may open up an avenue of drug discovery for this disease and others. In the June 12 issue of Nature, they report that agents ...
Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.
... is the first to make use of alternate morpheein shapes as a potential strategy for drug discovery, in general, particularly for antibiotics.
"Multi-drug resistance drives the need for developing ...
Potential Alzheimer's drugs go after plaque-forming protein substrate rather than its activating enzyme
... 70% of all therapeutic drugs so an increased understanding of them is vital for future drug discoveries," said Centenary Institute Executive Director, Professor Mathew Vadas.
Publishing this month ...
